FIELD: chemistry.
SUBSTANCE: substituted pyrimidinyl pyrrole compounds or pharmaceutically acceptable salts thereof are selected from the group consisting of 5-(2-aminopyrimidin-4-yl)-2-[2-chloro-5-(trifluoromethyl) phenyl]-1H-pyrrole-3-carboxamide, 5-(2-aminopyrimidin-4-yl)-2-(2,5-dichlorophenyl)-1H-pyrrole-3-carboxamide, 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-ethylphenyl)-1H-pyrrole-3-carboxamide, 5-(2-minopyrimidin-4-yl)-2-[2-ethyl-5-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide, 5-(2-aminopyrimidin-4-yl)-2-(5-chloro-2-ethylphenyl)-N-methyl-1H-pyrrole-3-carboxamide, 5-(2-aminopyrimidin-4-yl)-2-(5 chloro-2-ethylphenyl)-N-ethyl-1H-pyrrole-3-carboxamide, 5-(2-aminopyrimidin-4-yl)-2-[2-chloro-5-(trifluoromethyl)phenyl]-N-methyl-1H-pyrrole-3-carboxamide, 2-(5-chloro-2-methylphenyl)-5-[2-(methylamino)pyrimidin-4-yl]-1H-pyrrole-3-carboxamide and 5-(2-aminopyrimidin-4-yl)-2-[2-ethyl-5-(trifluoromethyl)phenyl]-N-methyl-1H-pyrrole-3-carboxamide. The invention also relates to versions of the method for preparation of these compounds. For example, the method may include the steps (1): metal-catalyzed coupling reaction of a halogenated derivative of formula
with a substituted phenylboronic acid of formula
or henylboronic acid ester of formula
,
(2) alkaline hydrolysis of the obtained carboxylic acid ester of formula
(3) amidation of the obtained carboxylic acid ester of formula
by a reaction with a derivative of formula (VI) NHR8R9, to obtain a compound of formula
wherein R1, R2, R3, R4, R8 and R9 values are given in the claims, and R12 is hydrogen; and if desired, convertion of a compound of formula (I) to a pharmaceutically acceptable salt or salt convertion to the free compound (I). Method versions include amidation of the carboxylic acid ester of formula (IV) without carboxylic acid (V) isolation or direct preparation of formula I compound without isolation of the intermediate compound of formula (IV) and (V). To prepare the formula I compound, where R12 is hydrogen, the method may include the steps of interaction of pyrrole of formula (VIII) with acetyl chloride to give compound IX, which forms enaminone X by reaction with dimethylformamide dialkyl acetal. Formulas VIII-XII are indicated in the claims.
EFFECT: compound X is reacted with guanidine or its salt of formula XI and hydrolysis of the obtained pyrimidinyl pyrrole nitrile of formula XII is carried out under acidic conditions.
10 cl, 1 tbl, 8 ex
алкил - alkyl
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS | 2013 |
|
RU2666538C2 |
MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR | 2011 |
|
RU2576036C2 |
2,3,5-TRISUBSTITUTED PYRROLS, BASED PHARMACEUTICAL COMPOSITION AND DRUG, METHOD FOR PREPARING COMPOUNDS (VERSIONS) | 2010 |
|
RU2549885C2 |
IMIDAZO[1,2-α]PYRIDINE-2-CABROXAMIDES, MAKING THEM AND APPLYING IN THERAPY | 2007 |
|
RU2441003C2 |
TRICYCLIC PYRROLE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND USE THEREOF AS KINASE INHIBITORS | 2012 |
|
RU2591191C2 |
SPIROCYCLIC AMINE DERIVATIVES AS S1P MODULATORS | 2011 |
|
RU2602800C2 |
CASR ANTAGONIST | 2004 |
|
RU2315036C2 |
NEW COMPOUNDS - NEUROKININ 1 RECEPTOR ANTAGONIZER | 2013 |
|
RU2631319C2 |
5-SUBSTITUTED INDAZOLE AS KINASE INHIBITORS | 2008 |
|
RU2487873C2 |
DIPEPTIDYL PEPTIDASE-IV INHIBITORS | 2010 |
|
RU2574410C2 |
Authors
Dates
2017-06-07—Published
2012-04-05—Filed